Danqing Q. Zhao
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
Sufficient-dose Brentuximab vedotin improves prognosis in patients with classic Hodgkin lymphoma: a single-center real-world study in China.
Journal: Frontiers in oncology
Published: May 24, 2026
Optimized interpretation of p53 immunohistochemistry for prediction of TP53 mutations and patient survival in DLBCL.
Journal: Clinical and experimental medicine
Published: March 10, 2026
Analysis of risk factors for infusion-related reactions in patients with B-cell lymphoma during obinutuzumab treatment.
Journal: Journal of chemotherapy (Florence, Italy)
Published: March 10, 2026
TP53 mutations and baseline lymphocytes indicate response to glofitamab in relapsed or refractory diffuse large B-cell lymphoma.
Journal: Annals of hematology
Published: February 24, 2026
Cytotoxic T-cell lymphoma with muscle involvement and germline variants in inborn error of immunity-related genes: clinical and genetic insights from a case series.
Journal: Haematologica
Published: February 06, 2026
Clonal haematopoiesis in T-follicular helper cell lymphoma: A prognostic biomarker and early event in lymphoma evolution.
Journal: British journal of haematology
Published: January 02, 2026
Efficient Isolation and Structural Characterization of Lignin from Xanthoceras sorbifolium Shell Using Ball-Milling-Assisted Deep Eutectic Solvent.
Journal: Biomacromolecules
Published: October 22, 2025
Real-World Comparative Analysis of Polatuzumab Vedotin-Based Polatuzumab Vedotin Combined with Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone versus Standard Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Diffuse Large B-Cell Lymphoma: A Propensity Score-Matched Cohort Study.
Journal: Oncology
Published: September 10, 2025
Preparation, antioxidant and immunomodulatory activities of selenium-modified galactomannan.
Journal: Food chemistry
Published: August 29, 2025
Successful Treatment of Diffuse Large B-Cell Lymphoma and Antisynthetase Syndrome with Bispecific Antibody Glofitamab.
Journal: Cancer management and research
Published: April 22, 2025
Breaking diagnostic and therapeutic barriers in intravascular large B-cell lymphoma: A 13-year real-world study from China.
Journal: Orphanet journal of rare diseases
Published: April 06, 2025
Germline defects of familial haemophagocytic lymphohistiocytosis-Related genes may represent a predisposing factor for mature T- and natural killer-cell lymphoma.
Journal: British journal of haematology
Published: March 13, 2025
Last Updated: 09/26/2026